215 related articles for article (PubMed ID: 29799330)
1. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
2. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
3. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
[TBL] [Abstract][Full Text] [Related]
4. Modeling Episode-Based Payments for Cancer Using Commercial Claims Data.
Polson M; Lord T; Evangelatos T; Kangethe A; Speicher LC; Barrientos S; Zacker C
J Manag Care Spec Pharm; 2019 Feb; 25(2):235-245. PubMed ID: 30698092
[TBL] [Abstract][Full Text] [Related]
5. Cost variation and savings opportunities in the Oncology Care Model.
Baumgardner J; Shahabi A; Zacker C; Lakdawalla D
Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495
[TBL] [Abstract][Full Text] [Related]
6. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
[TBL] [Abstract][Full Text] [Related]
7. Costs and clinical quality among Medicare beneficiaries: associations with health center penetration of low-income residents.
Sharma R; Lebrun-Harris LA; Ngo-Metzger Q
Medicare Medicaid Res Rev; 2014; 4(3):. PubMed ID: 25243096
[TBL] [Abstract][Full Text] [Related]
8. Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.
Chen C; Petterson S; Phillips R; Bazemore A; Mullan F
JAMA; 2014 Dec; 312(22):2385-93. PubMed ID: 25490329
[TBL] [Abstract][Full Text] [Related]
9. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in spending and survival for older adults with advanced cancer.
Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
[TBL] [Abstract][Full Text] [Related]
11. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
[TBL] [Abstract][Full Text] [Related]
12. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
13. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer.
Tannenbaum S; Soulos PR; Herrin J; Mougalian S; Long JB; Wang R; Ma X; Gross CP; Xu X
Med Care; 2017 Dec; 55(12):1030-1038. PubMed ID: 29068906
[TBL] [Abstract][Full Text] [Related]
14. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.
Wang S; Hsu SH; Huang S; Soulos PR; Gross CP
Health Aff (Millwood); 2017 Feb; 36(2):328-336. PubMed ID: 28167723
[TBL] [Abstract][Full Text] [Related]
15. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
16. Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapies.
Youn B; Wilson IB; Mor V; Trikalinos NA; Dahabreh IJ
Health Serv Res; 2021 Jun; 56(3):486-496. PubMed ID: 33682120
[TBL] [Abstract][Full Text] [Related]
17. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
[TBL] [Abstract][Full Text] [Related]
18. Geographic correlation between large-firm commercial spending and Medicare spending.
Chernew ME; Sabik LM; Chandra A; Gibson TB; Newhouse JP
Am J Manag Care; 2010 Feb; 16(2):131-8. PubMed ID: 20148618
[TBL] [Abstract][Full Text] [Related]
19. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.
Donohue JM; Normand SL; Horvitz-Lennon M; Men A; Berndt ER; Huskamp HA
J Ment Health Policy Econ; 2016 Jun; 19(2):69-78. PubMed ID: 27453458
[TBL] [Abstract][Full Text] [Related]
20. Physician Participation in Medicare Accountable Care Organizations and Spillovers in Commercial Spending.
Post B; Ryan AM; Moloci NM; Li J; Dupree JM; Hollingsworth JM
Med Care; 2019 Apr; 57(4):305-311. PubMed ID: 30789539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]